Please provide your email address to receive an email when new articles are posted on . From April 2016 to November 2019, researchers enrolled 36 children with unilateral refractive amblyopia and ...

The purpose of the study was to evaluate the feasibility and acceptability of utilizing elbow splints as a method of increasing amblyopic patching compliance in pediatric ophthalmology patients who ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Luminopia today announced the publication of positive Phase 3 pivotal data of its investigational treatment for amblyopia—Luminopia One TM —in Ophthalmology Ⓡ, the ...

About 69% of pediatric patients had discontinued amblyopia therapy during COVID-19 even as their parents reported that adherence was good. Although parents reported good adherence to therapy, a new ...

Luminopia, Inc., a digital health company pioneering a new class of treatments for neuro-visual disorders, announced its first international licensing agreement with ROHTO Pharmaceutical Co., LTD, a ...

According to the final “ThemenCheck” report, no studies are available on non-digital vision training or vision training for other developmental vision disorders. Institute for Quality and Efficiency ...

Please provide your email address to receive an email when new articles are posted on . The FDA has granted de novo premarket approval for Luminopia One, a digital therapy for children aged 4 to 7 ...

Credit: Getty Images. With Luminopia One, patients watch therapeutically modified TV shows and movies to improve their vision within a virtual reality headset. The Food and Drug Administration (FDA) ...

In the "ThemenCheck Medizin" procedure offered by the German Institute for Quality and Efficiency in Health Care (IQWiG), interested members of the public can submit proposals for the assessment of ...

Amblyopia is the most common cause of vision loss in children, according to the U.S. National Eye Institute. It arises when visual experience is disrupted during infancy, for example by a cataract in ...